Literature DB >> 21535918

Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study.

Emma Ådén1, Maine Carlsson, Eric Poortvliet, Hans Stenlund, Jan Linder, Mona Edström, Lars Forsgren, Lena Håglin.   

Abstract

OBJECTIVE: To evaluate energy and nutrient intake in newly diagnosed Parkinson's disease (PD) patients and association between olfaction and nutrient density of the diet.
DESIGN: Baseline data from a prospective cohort study.
SUBJECTS: Eighty-seven patients and 28 age- and sex-matched controls participated in the study.
METHODS: Dietary intake was assessed by using 3-day dietary records and 24-hour dietary recalls. The Brief Smell Identification Test (B-SIT) was used to test olfaction.
RESULTS: Patients, compared with controls, had lower intake of polyunsaturated fatty acids (P = 0.024) and a higher intake of carbohydrates (P = 0.027) in energy percent (E%). Lower intake of protein (E%) (P = 0.045), and a low nutrient density of folate (P = 0.022), magnesium (P = 0.012), and phosphorus (P = 0.029) were associated with lower B-SIT score in both patients and controls. PD patients had a lower B-SIT score than controls (P < 0.001).
CONCLUSION: The results indicate a higher relative contribution of energy from carbohydrates in PD patients. An association between low protein, folate, magnesium, and phosphorus density of the diet and olfaction was seen in the whole population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21535918     DOI: 10.1179/174313211X12966635733312

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  24 in total

1.  Olfactory Function, Eating Ability, and Visceral Obesity Associated with MMSE Three Years after Parkinson's Disease Diagnosis.

Authors:  M Vikdahl; M E Domellöf; L Forsgren; L Håglin
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

Review 2.  Changes of Olfactory Performance during the Process of Aging - Psychophysical Testing and Its Relevance in the Fight against Malnutrition.

Authors:  W Gunzer
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 3.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

4.  SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease.

Authors:  Morgan Sturgeon; Perry Wu; Robert Cornell
Journal:  J Neurol Neuromedicine       Date:  2016-12-30

5.  Intake of vitamin B before onset of Parkinson's disease and atypical parkinsonism and olfactory function at the time of diagnosis.

Authors:  L Håglin; I Johansson; L Forsgren; L Bäckman
Journal:  Eur J Clin Nutr       Date:  2016-10-05       Impact factor: 4.016

Review 6.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

7.  Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking.

Authors:  James D Sharer; Fidias E Leon-Sarmiento; James F Morley; Daniel Weintraub; Richard L Doty
Journal:  Mov Disord       Date:  2014-12-27       Impact factor: 10.338

8.  Olfactory impairment in older adults is associated with poorer diet quality over 5 years.

Authors:  Bamini Gopinath; Joanna Russell; Carolyn M Sue; Victoria M Flood; George Burlutsky; Paul Mitchell
Journal:  Eur J Nutr       Date:  2015-05-10       Impact factor: 5.614

9.  Folic Acid Deficiency Enhances the Tyr705 and Ser727 Phosphorylation of Mitochondrial STAT3 in In Vivo and In Vitro Models of Ischemic Stroke.

Authors:  Zhiping Dong; Xiaoshan Liang; Qiang Zhang; Suhui Luo; Huan Liu; Xuan Wang; Na Sai; Xumei Zhang
Journal:  Transl Stroke Res       Date:  2020-10-10       Impact factor: 6.829

10.  Substitution p.A350V in Na⁺/Mg²⁺ exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutation.

Authors:  Martin Kolisek; Gerhard Sponder; Lucia Mastrototaro; Alina Smorodchenko; Pierre Launay; Juergen Vormann; Monika Schweigel-Röntgen
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.